C A Hoefnagel
Overview
Explore the profile of C A Hoefnagel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoefnagel C, Rutgers M, Buitenhuis C, Smets L, Kraker J, Meli M, et al.
Eur J Nucl Med
. 2014 Mar;
28(3):359-68.
PMID: 24623005
Iodine-131 labelled anti L1-CAM antibody mAb chCE7 was compared with the effective neuroblastoma-seeking agent (131)I-labelled metaiodobenzylguanidine (MIBG) with regard to (a) its therapeutic efficacy in treating nude mice with neuroblastoma...
2.
Kartachova M, Verheij M, van Eck B, Hoefnagel C, Valdes Olmos R
Clin Med Oncol
. 2011 Sep;
2:319-25.
PMID: 21892293
Radionuclide detection of apoptosis with of (99m)Tc-Hynic-rh-Annexin V scintigraphy is an effective tool for in vivo visualisation and monitoring of apoptosis in various malignant tumour. Early therapy-induced increase of the...
3.
Tran L, Baars J, de Boer J, Hoefnagel C, Beijnen J, Huitema A
Hum Antibodies
. 2011 May;
20(1-2):37-40.
PMID: 21558622
Purpose: To report the pharmacokinetics of ¹³¹I-rituximab a patient with a CD20 positive non-Hodgkin Lymphoma who has received ¹³¹I-rituximab as consolidation treatment after remission induction and to evaluate the effect...
4.
Vidal-Sicart S, Aukema T, Vogel W, Hoefnagel C, Valdes-Olmos R
Rev Esp Med Nucl
. 2010 Jul;
29(5):230-5.
PMID: 20624663
Aim: This study has aimed to assess if the prone position shows significant differences in regards to the supine position in PET/CT studies in breast cancer patients and to determine...
5.
Vermeeren L, Valdes Olmos R, Meinhardt W, Bex A, van der Poel H, Vogel W, et al.
Eur J Nucl Med Mol Imaging
. 2009 Mar;
36(7):1029-36.
PMID: 19288098
Purpose: Our aim was to assess the feasibility of intraoperative radioguidance with a portable gamma camera during laparoscopic sentinel node (SN) procedures in urological malignancies. Methods: We evaluated the use...
6.
Kroon B, Hoefnagel C, Valdes Olmos R, Nieweg O
Ned Tijdschr Geneeskd
. 2008 Oct;
152(37):1997-2000.
PMID: 18825884
In 3 patients, two men aged 22 years and 38 years with melanoma, and one woman aged 46 years with breast cancer, local tumour growth recurred following regional lymph node...
7.
Estourgie S, Valdes Olmos R, Nieweg O, Hoefnagel C, Rutgers E, Kroon B
Br J Surg
. 2007 May;
94(9):1088-91.
PMID: 17514636
Background: The aim was to validate the sentinel node biopsy procedure in women who had previous breast excision biopsy by means of determining the reproducibility of lymphoscintigraphy after surgery. Methods:...
8.
van der Poel H, Antonini N, Hoefnagel C, Horenblas S, Valdes Olmos R
Urol Int
. 2006 Jul;
77(1):50-6.
PMID: 16825816
Objective: Retrospective comparative analysis of strontium-89 chloride (Sr89) and rhenium-186-hydroxyethylidene diphosphonate (Re186-HEDP) radionuclide treatment to find predictors of response in patients with painful metastases from hormone refractory prostate cancer. Patients...
9.
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours
Zuetenhorst J, Valdes Olmos R, Muller M, Hoefnagel C, Taal B
Endocr Relat Cancer
. 2004 Sep;
11(3):553-61.
PMID: 15369454
Interferon (IFN) and meta-iodobenzylguanidin (MIBG) are active in metastatic carcinoids. In a phase II study, we evaluated the effect upon diagnostic 131I-MIBG uptake and the clinical response of the combination....
10.